Helicos' Q4 Grant Revenues Double; Expects Instrument Revenue in '09 | GenomeWeb

NEW YORK (GenomeWeb News) – Helicos BioSciences reported in a filing with the US Securities and Exchange Commission yesterday after the close of the market that its fourth-quarter grant revenues increased to $206,000 from $117,000 year over year.

The firm also reported its first ever product revenue, totaling $36,000 for the three-month period ended Dec. 31, 2008. The company said in the filing that it expects to "recognize revenue from one of our initial 2008 instrument shipments in 2009."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.